WST · West Pharmaceutical Services Inc · Insider Trading

Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.

This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019.

This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019.

This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019.

This award granted on February 21, 2017 vested in four equal annual installments beginning on February 21, 2018.

Each restricted stock unit represents a contingent right to receive one share of WST common stock.

This award vests in four equal annual installments beginning on September 8, 2027.

The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price resulting in such weighted average price.

This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019.

This award vests in four equal annual installments beginning on September 8, 2027.

This award cliff vests on September 8, 2031.

The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price resulting in such weighted average price.

The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price resulting in such weighted average price.

This award vests in four equal annual installments beginning on September 8, 2027.

Each restricted stock unit represents a contingent right to receive one share of WST common stock.

This award vests in four equal annual installments beginning on September 8, 2027.

This award granted on February 21, 2017 vested in four equal annual installments beginning on February 21, 2018.

Each restricted stock unit represents a contingent right to receive one share of WST common stock.

This award cliff vests on September 8, 2031.

Each restricted stock unit represents a contingent right to receive one share of WST common stock.

Each restricted stock unit represents a contingent right to receive one share of WST common stock.

On August 11, 2025, the reporting person was granted 12,670 restricted stock units, vesting in three installments - 4,223 shares (plus dividend equivalents) to vest six months from the grant date, 6,335 shares (plus dividend equivalents) to vest 12 months from the grant date and 2,112 shares (plus dividend equivalents) to vest 24 months from the grant date.

Each restricted stock unit represents a contingent right to receive one share of WST common stock.

This award vests in four equal annual installments beginning on August 11, 2026.

Each restricted stock unit represents a contingent right to receive one share of WST common stock.

Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.

Restricted stock units convert into common stock on a one-for-one basis.

On May 12, 2025, the reporting person was granted 1,182 restricted stock units, vesting in four equal annual installments (plus dividend equivalents).

Restricted stock units convert into common stock on a one-for-one basis.

Restricted stock units convert into common stock on a one-for-one basis.

On May 12, 2025, the reporting person was granted 1,891 restricted stock units, vesting in four equal annual installments (plus dividend equivalents).

Restricted stock units convert into common stock on a one-for-one basis.

These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting.

These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting.

These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting.

These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting.

The price reported in Column 4 is a weighted average price.